Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships

Autor: Indy Sandaradura, Sahand Imani, Deborah Marriott, Hergen Buscher, Sheridan Gentili
Přispěvatelé: Imani, Sahand, Buscher, Hergen, Marriott, Debbie, Gentili, Sheridan, Sandaradura, Indy
Rok vydání: 2017
Předmět:
Male
0301 basic medicine
Gastroenterology
antibiotics
Cohort Studies
0302 clinical medicine
meropenem
piperacillin
polycyclic compounds
Pharmacology (medical)
lactams
030212 general & internal medicine
toxic effect
medicine.diagnostic_test
nephrotoxicity
Incidence
Bacterial Infections
Middle Aged
Anti-Bacterial Agents
Infectious Diseases
Toxicity
neurotoxicity syndromes
Female
Neurotoxicity Syndromes
Drug Monitoring
medicine.drug
Adult
Microbiology (medical)
hepatotoxicity
medicine.medical_specialty
Drug-Related Side Effects and Adverse Reactions
floxacillin
030106 microbiology
Microbial Sensitivity Tests
beta-Lactams
Meropenem
Floxacillin
Nephrotoxicity
03 medical and health sciences
Cmin
Internal medicine
medicine
Humans
Adverse effect
Aged
Retrospective Studies
Piperacillin
Pharmacology
business.industry
Therapeutic drug monitoring
Clostridium Infections
Thienamycins
Flucloxacillin
business
Zdroj: Journal of Antimicrobial Chemotherapy. 72:2891-2897
ISSN: 1460-2091
0305-7453
DOI: 10.1093/jac/dkx209
Popis: Objectives To determine the existence of concentration-toxicity relationships for common β-lactam antibiotic adverse effects and define thresholds above which toxicity is more likely. Patients and methods: Retrospective review of consecutive patients treated with piperacillin, meropenem or flucloxacillin who underwent therapeutic drug monitoring (TDM) at St Vincent’s Hospital (Sydney, Australia) between January 2013 and December 2015. Adverse events investigated included neurotoxicity, nephrotoxicity, hepatotoxicity and opportunistic Clostridium difficile infection. Toxicity was measured using observational grading criteria, clinical assessment and relevant serum biomarkers. These findings were correlated with trough TDM measurements at the time of toxicity presentation. Results: TDM results from 378 patients (piperacillin = 223, meropenem = 94 and flucloxacillin = 61) were investigated. There was no difference in baseline patient characteristics across antibiotic groups. A statistically significant elevation in mean serum trough concentrations (Cmin) was found in patients diagnosed with neurotoxicity (piperacillin, P 361.4 mg/L; meropenem, Cmin >64.2 mg/L; flucloxacillin, Cmin >125.1 mg/L) or nephrotoxicity (piperacillin, Cmin >452.65 mg/L; meropenem, Cmin >44.45 mg/L) varied across antibiotics. Conclusions: Our data reveal an association between toxic concentrations for a number of β-lactam agents and neurotoxic/nephrotoxic effects. We have defined threshold concentrations above which these toxicities become more likely. Clinicians should balance concerns for therapeutic efficacy with potential toxicity when considering aggressive therapy. Refereed/Peer-reviewed
Databáze: OpenAIRE